|
gptkbp:instance_of
|
gptkb:patches
|
|
gptkbp:age_group
|
18 years and older
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:available_in
|
syringe
|
|
gptkbp:brand
|
gptkb:Juvederm
|
|
gptkbp:capacity
|
1.0 m L
|
|
gptkbp:clinical_trial
|
Phase 3
demonstrated efficacy
demonstrated safety
|
|
gptkbp:clinical_use
|
aesthetic medicine
|
|
gptkbp:contains
|
hyaluronic acid
|
|
gptkbp:contraindication
|
pregnancy
breastfeeding
active skin infection
allergy to hyaluronic acid
|
|
gptkbp:crosslinking
|
Vycross technology
|
|
gptkbp:customer_satisfaction
|
high
|
|
gptkbp:duration
|
up to 1 year
|
|
gptkbp:duration_of_procedure
|
15-30 minutes
|
|
gptkbp:events
|
recommended
|
|
gptkbp:formulation
|
injectable gel
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Juvederm Volbella XC
|
|
gptkbp:injection_type
|
subcutaneous injection
|
|
gptkbp:is_targeted_at
|
lips
perioral area
|
|
gptkbp:launch_date
|
gptkb:2016
|
|
gptkbp:manufacturer
|
gptkb:Abb_Vie
|
|
gptkbp:marketed_as
|
Volbella
|
|
gptkbp:produced_by
|
gptkb:Allergan
|
|
gptkbp:recommissioned
|
not required
|
|
gptkbp:route_of_administration
|
performed by licensed professional
|
|
gptkbp:side_effect
|
bruising
swelling
redness
pain at injection site
|
|
gptkbp:specialties
|
ice application
avoid sun exposure
avoid alcohol
avoid strenuous exercise
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:used_for
|
wrinkle treatment
lip augmentation
|
|
gptkbp:viscosity_grade
|
low
|
|
gptkbp:website
|
linear threading
serial puncture
|
|
gptkbp:bfsParent
|
gptkb:Juvederm
|
|
gptkbp:bfsLayer
|
6
|